|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1996-11-12
|
|
pubmed:abstractText |
We studied retrospectively the interaction between c-erbB2 overexpression and adjuvant tomoxifen in node-negative breast cancer patients enrolled in the Gruppo Universitario Napoletano 1 (GUN-1) trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BiancoA RAR,
pubmed-author:CarlomagnoCC,
pubmed-author:D'AntonioAA,
pubmed-author:De LaurentiisMM,
pubmed-author:De PlacidoSS,
pubmed-author:GalloCC,
pubmed-author:LauriaRR,
pubmed-author:MorabitoAA,
pubmed-author:PanicoLL,
pubmed-author:PerroneFF,
pubmed-author:PettinatoGG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2702-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:8874330-Adult,
pubmed-meshheading:8874330-Aged,
pubmed-meshheading:8874330-Antineoplastic Agents, Hormonal,
pubmed-meshheading:8874330-Axilla,
pubmed-meshheading:8874330-Breast Neoplasms,
pubmed-meshheading:8874330-Female,
pubmed-meshheading:8874330-Follow-Up Studies,
pubmed-meshheading:8874330-Humans,
pubmed-meshheading:8874330-Lymphatic Metastasis,
pubmed-meshheading:8874330-Middle Aged,
pubmed-meshheading:8874330-Neoplasm Proteins,
pubmed-meshheading:8874330-Receptor, erbB-2,
pubmed-meshheading:8874330-Tamoxifen
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
|
|
pubmed:affiliation |
Divisione di Oncologia Medica, Facoltà di Medicina-Università degli Studi Federico II, Napoli, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
